Lexicon Pharmaceuticals
LXRX
#6805
Rank
C$1.10 B
Marketcap
C$2.48
Share price
-4.40%
Change (1 day)
14.86%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total assets

Total assets on the balance sheet as of June 2026 : C$0.35 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total assets are C$0.35 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lexicon Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31C$0.25 B-40.84%
2024-12-31C$0.42 B40.72%
2023-12-31C$0.30 B15.42%
2022-12-31C$0.26 B51.11%
2021-12-31C$0.17 B-32.85%
2020-12-31C$0.25 B-52.37%
2019-12-31C$0.54 B40.95%
2018-12-31C$0.38 B-29.48%
2017-12-31C$0.54 B-14.13%
2016-12-31C$0.63 B-29.33%
2015-12-31C$0.90 B65.33%
2014-12-31C$0.54 B87.44%
2013-12-31C$0.29 B-21.06%
2012-12-31C$0.36 B-15.58%
2011-12-31C$0.43 B19.41%
2010-12-31C$0.36 B35.22%
2009-12-31C$0.27 B-14.7%
2008-12-31C$0.31 B-13.69%
2007-12-31C$0.36 B66.3%
2006-12-31C$0.22 B-13%
2005-12-31C$0.25 B0.01%
2004-12-31C$0.25 B-30.94%
2003-12-31C$0.36 B15.68%
2002-12-31C$0.31 B-16.65%
2001-12-31C$0.38 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Thermo Fisher Scientific
TMO
C$161.49 B 45,158.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$9.35 B 2,522.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$59.54 B 16,588.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C$1.80 B 405.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$3.11 B 774.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.65 B 84.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C$0.53 B 50.20%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$16.72 B 4,588.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$9.01 M-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA